Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial
Porter, Duncan, van Melckebeke, Jurgen, Dale, James, Messow, C Martina, McConnachie, Alexander, Walker, Andrew, Munro, Robin, McLaren, John, McRorie, Euan, Packham, Jon, Buckley, Christopher D, HarvieLangue:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(16)00380-9
Date:
May, 2016
Fichier:
PDF, 300 KB
english, 2016
File converter
Plus de résultats de recherche
More benefits 
